BIOPROGNOSIS Trademark

Trademark Overview


On Monday, July 12, 2021, a trademark application was filed for BIOPROGNOSIS with the United States Patent and Trademark Office. The USPTO has given the BIOPROGNOSIS trademark a serial number of 90822231. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Saturday, December 2, 2023. This trademark is owned by Renalytix AI, Inc.. The BIOPROGNOSIS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Development of new technology for others in the field of medical devices and medical diagnostic apparatuses for predicting the relative risk of progression of kidney, heart, and liver diseases and kidney, heart, and liver health; research, development and consultation related thereto in the field of medical devices and medical diagnostic apparatuses through the use of artificial intelligence; laboratory research in the field of kidney, heart, and liver health and kidney, heart, and liver diseases; medical research services relating to kidney, heart, and liver health; research and development services in the field of antibodies relating to kidney, heart, and liver health; computer software development; providing temporary use of on-line non-downloadable software and software applications using artificial intelligence for medical analysis; providing temporary use of on-line non-downloadable software and software applications for creating analytic and statistic models for data analysis in...
bioprognosis

General Information


Serial Number90822231
Word MarkBIOPROGNOSIS
Filing DateMonday, July 12, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateSaturday, December 2, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkBIO PROGNOSIS
Goods and ServicesDevelopment of new technology for others in the field of medical devices and medical diagnostic apparatuses for predicting the relative risk of progression of kidney, heart, and liver diseases and kidney, heart, and liver health; research, development and consultation related thereto in the field of medical devices and medical diagnostic apparatuses through the use of artificial intelligence; laboratory research in the field of kidney, heart, and liver health and kidney, heart, and liver diseases; medical research services relating to kidney, heart, and liver health; research and development services in the field of antibodies relating to kidney, heart, and liver health; computer software development; providing temporary use of on-line non-downloadable software and software applications using artificial intelligence for medical analysis; providing temporary use of on-line non-downloadable software and software applications for creating analytic and statistic models for data analysis in the field of kidney, heart, and liver health and kidney, heart, and liver disease

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 16, 2021
Primary Code042
First Use Anywhere DateWednesday, June 30, 2021
First Use In Commerce DateWednesday, June 30, 2021

Trademark Owner History


Party NameRenalytix AI, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10036

Trademark Events


Event DateEvent Description
Monday, December 4, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Saturday, December 2, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Saturday, December 2, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, July 13, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, July 13, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, April 20, 2023NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Wednesday, April 19, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 19, 2023NON-FINAL ACTION E-MAILED
Wednesday, April 19, 2023NON-FINAL ACTION WRITTEN
Wednesday, April 19, 2023USE AMENDMENT ACCEPTED
Tuesday, March 14, 2023AMENDMENT TO USE PROCESSING COMPLETE
Tuesday, March 14, 2023USE AMENDMENT FILED
Monday, March 13, 2023TEAS AMENDMENT OF USE RECEIVED
Monday, March 13, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 13, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 13, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 12, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 12, 2022NON-FINAL ACTION E-MAILED
Monday, September 12, 2022NON-FINAL ACTION WRITTEN
Thursday, August 11, 2022ASSIGNED TO EXAMINER
Tuesday, July 5, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 5, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 5, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 6, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 6, 2022NON-FINAL ACTION E-MAILED
Thursday, January 6, 2022NON-FINAL ACTION WRITTEN
Monday, January 3, 2022ASSIGNED TO EXAMINER
Wednesday, November 17, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 17, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, November 17, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 17, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 16, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 15, 2021NEW APPLICATION ENTERED